Industrial Purity Specifications and COA Standards for 4,4,5,5,5-Pentafluoro-1-pentanol
- Critical Purity Thresholds: Pharmaceutical-grade batches typically require >99% purity to ensure downstream API synthesis efficiency.
- Analytical Verification: Comprehensive COA documentation must include 1H-NMR, GC, and HPLC data to validate structural integrity.
- Supply Chain Stability: Reliable global manufacturers offer bulk pricing and consistent lot-to-lot reproducibility for scale-up.
In the realm of advanced fluorinated chemistry, 4,4,5,5,5-Pentafluoro-1-pentanol (CAS: 148043-73-6) stands as a critical building block for high-value pharmaceutical intermediates. This colorless liquid is primarily utilized in the commercial manufacture of active pharmaceutical ingredients (APIs), most notably as a key precursor in the synthesis of Fulvestrant, a medication used to treat hormone receptor-positive metastatic breast cancer. For process chemists and procurement specialists, understanding the nuanced industrial purity specifications is vital to preventing catalyst poisoning and ensuring high reaction yields in subsequent steps.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to strict quality control protocols to deliver batches that meet rigorous international standards. The chemical structure, defined by the molecular formula C5H7F5O and a molecular weight of 178.1 g/mol, presents unique handling challenges due to its fluorinated chain. Ensuring the absence of isomeric impurities and residual solvents is paramount for maintaining the efficacy of the final drug product.
Key Physical and Chemical Properties
When evaluating technical data sheets, buyers must verify specific physical constants to confirm identity and quality. Deviations in boiling point or density often indicate contamination with non-fluorinated analogs or incomplete reaction products. The following table outlines the standard specifications expected for high-grade material:
| Property | Specification | Test Method |
|---|---|---|
| CAS Number | 148043-73-6 | N/A |
| Molecular Formula | C5H7F5O | N/A |
| Appearance | Clear colorless liquid | Visual |
| Purity (GC) | >98.0% - 99.0% | Gas Chromatography |
| Boiling Point | 62-64 °C at 35 mm Hg | Distillation |
| Density | 1.35 g/mL at 25 °C | Pycnometer |
| Refractive Index | Standard Range | Refractometer |
| Storage Temperature | 2-8°C | N/A |
Understanding Certificate of Analysis (COA) Requirements
A robust Certificate of Analysis (COA) is the cornerstone of quality assurance in bulk chemical procurement. For 4,4,5,5,5-pentafluoropentanol, a standard COA should not merely list purity percentages but must provide detailed chromatographic data. Industrial buyers should request documentation that includes 1H-NMR spectra to confirm the positioning of the fluorine atoms on the pentyl chain. Additionally, mass spectrometry (MS) and IR data are essential to rule out structural isomers that could compromise the synthesis route of the final API.
Impurity profiles are particularly critical. Common contaminants may include unreacted starting materials or side products from the fluorination process. High-performance liquid chromatography (HPLC) and gas chromatography (GC) are the standard methods for quantifying these impurities. A reputable supplier will provide batch-specific data showing that residual heavy metals and moisture content are within acceptable limits, typically below 0.5% for water content in anhydrous grades.
Manufacturing Process and Synthesis Optimization
The manufacturing process for this fluorinated alcohol often begins with pentafluoroiodoethane as a starting material. In a typical industrial setup, the synthesis involves reacting pentafluoroiodoethane with allyl alcohol under an inert gas atmosphere. Catalysts such as iron acetylacetonate and ligands like 6,6'-dimethyl-2,2'-bipyridine are employed to facilitate the coupling reaction. Process optimization focuses on maximizing yield while minimizing the formation of polymeric byproducts.
Recent advancements in this synthesis route have demonstrated yields exceeding 90.4% when reaction conditions are tightly controlled at temperatures around 80 °C. Post-reaction processing involves quenching with hydrochloric acid, phase separation, and precise fractional distillation to isolate the target alcohol. The efficiency of this distillation step directly impacts the bulk price and overall availability of the material, as higher purity requires more energy-intensive separation techniques.
Applications in Pharmaceutical and Material Science
Beyond its role in oncology drug development, Pentafluoropentanol serves as a versatile solvent in various chemical reactions. Its unique properties enhance reaction efficiency and selectivity, particularly in fluorination processes where traditional solvents may fail. In material science, the compound is applied in the development of advanced coatings and polymers, offering enhanced durability and resistance to harsh solvents.
For procurement teams sourcing this chemical for large-scale production, consistency is key. When sourcing high-purity 4,4,5,5,5-Pentafluoro-1-pentanol, buyers should prioritize suppliers who can demonstrate lot-to-lot reproducibility. This ensures that downstream processing parameters do not require constant adjustment, thereby reducing manufacturing costs and timeline risks.
Procurement Guidelines and Safety Considerations
Safety data sheets (SDS) indicate that this compound is flammable and may cause eye irritation (H319). Proper personal protective equipment (PPE), including eyeshields and gloves, is mandatory during handling. Storage should be maintained between 2-8°C to prevent degradation. From a logistical perspective, incoterms such as CPT (Carriage Paid To) are commonly used for international shipments. Buyers should verify that the supplier complies with local regulations regarding the transport of fluorinated substances.
NINGBO INNO PHARMCHEM CO.,LTD. provides comprehensive after-sales support, including technical assistance from R&D teams to help integrate this intermediate into complex synthetic pathways. By partnering with a dedicated manufacturer, clients gain access to stable supply chains and competitive pricing structures that accommodate both pilot-scale and commercial production needs.
Conclusion
In summary, the successful integration of 4,4,5,5,5-Pentafluoro-1-pentanol into pharmaceutical manufacturing relies on strict adherence to purity specifications and comprehensive analytical verification. Understanding the technical nuances of the COA, the manufacturing process, and the physical properties ensures that process chemists can achieve optimal yields. With the right supply partner, organizations can secure the high-quality intermediates necessary for developing next-generation therapeutics and advanced materials.